Viewing Study NCT04667312


Ignite Creation Date: 2025-12-26 @ 11:11 PM
Ignite Modification Date: 2025-12-26 @ 11:11 PM
Study NCT ID: NCT04667312
Status: COMPLETED
Last Update Posted: 2023-10-02
First Post: 2020-11-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Observational Study of Durvalumab in Patients With Non-small-cell Lung Cancer in the United Kingdom
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module